Both MAP3K21 and PCNX2 have no previous evidence of an effect in the vasculature, but have an implicated role in cancers, such as breast cancer metastasis [18], glioblastomas [19] (MAP3K21), and thyroid cancer (PCNX2) [20]. This evidence concerns the gene MAP3K21 and thyroid cancer.